Shares of Insecticides (India) Limited dropped more than 9% on Friday, January 30, after the company reported a significant decline in profitability for the December quarter. According to reports from CNBC TV18, Rediff Money, and The Economic Times, the agrochemicals maker's consolidated net profit dropped 39.7% year-on-year to ₹10.5 crore in Q3 FY26, compared with ₹17.4 crore in the same period last year. The market's response was immediate and severe, with the stock price tumbling during trading and closing at ₹596.3, marking a 7.7% drop from the previous close.
Despite the profit decline, revenue from operations grew 7.6% year-on-year to ₹385 crore, up from ₹357.85 crore, aided by higher sales volumes. However, the company's operating performance remained under pressure, with EBITDA falling 11% to ₹27.5 crore from the previous year. The company attributed the revenue increase primarily to higher sales volumes within its single business segment of Agro-Chemicals, but this topline growth failed to translate into corresponding bottom-line improvement due to the significant increase in operational costs. As reported by The Economic Times, management attributed these margin pressures to persistently elevated input costs and increased operating expenses, which eroded profitability gains from higher sales.
The company's EBITDA margin narrowed by 150 basis points to 7.1% from 8.6%, reflecting elevated input costs and operating expenses. According to The Economic Times, this pressure on margins was a direct result of elevated input costs and increased operating expenses, which negated the benefits of higher sales. The significant drop in margins indicates that higher raw material prices and operational overheads are eroding profitability, with the company struggling to manage costs effectively despite successful sales volume growth. The margin compression was particularly pronounced given the company's inability to offset cost pressures through pricing power.
In a separate development, the board declared an interim dividend of ₹2 per equity share (20%) for FY26. The record date has been fixed as February 6, 2026, with the dividend to be paid on or after February 11, 2026. This dividend announcement provided some support to investors amid the profitability concerns, though it failed to offset the market's negative reaction to the disappointing operational performance, as reported by The Economic Times.
Shares of Insecticides India are trading 7.7% lower after the earnings announcement at ₹596.3. The stock has experienced significant pressure over the longer term, declining 45% over the last six months, reflecting ongoing operational challenges in the agrochemicals sector. The quarterly performance has compounded these concerns, with investors focusing on the company's inability to translate revenue growth into corresponding profit growth, highlighting underlying cost pressures and lack of pricing power despite successful volume expansion. The company's market capitalization hovers around ₹1,850-1,900 crore, with a reported P/E ratio of approximately 12.6x, which is lower than many larger peers such as UPL (around 22.3x) and PI Industries (around 31.8x), suggesting a valuation discount.
